First episode of chronic anterior uveitis in patients with juvenile idiopathic arthritis and relationship with administrated treatments by Alina Boteanu et al.
POSTER PRESENTATION Open Access
First episode of chronic anterior uveitis in
patients with juvenile idiopathic arthritis and
relationship with administrated treatments
Alina Lucica Boteanu*, Carmen Velazquez Arce, Carlos Guillen Astete, Maria Angeles Blazquez Cañamero,
Maria Luz Gámir Gámir
From 21st European Pediatric Rheumatology (PReS) Congress
Belgrade, Serbia. 17-21 September 2014
Introduction
Chronic anterior uveitis is one of the most serious compli-
cations of juvenile idiopathic arthritis (JIA), showing an
increased incidence in patients with early-onset disease,
oligoarticualar, ANA (+). Biologic therapy used in the
treatment of JIA has greatly improved the articular prog-
nosis, however their effectiveness in JIA associated uveitis
is still not well established, having reported new cases of
uveitis during treatment with anti -TNF, especially during
treatment with etanercept.
Objectives
The objective of this work is to report the incidence of
new cases of chronic anterior uveitis in patients who
were treated with Methotrexate (MTX), Adalimumab
(ADM) or Etanercept (ETN) for JIA.
Methods
We performed a retrospective observational study of
70 patients with diagnosis of early-onset JIA with high risk
of developing chronic anterior uveitis. There were
recorded the new episodes of uveitis per patient. Incidence
was calculated as the number of new episodes per
100 patients per year of follow-up according to the ILAR
category and treatment and based exclusively on the treat-
ment. Comparisons were made using T Student test.
Results
Fifty-six (80.0%) patients were female and 14 (20.0%)
males. The categories ILAR were: 42 (60.0%) oligoarticu-
lar, 10 (14.3%) extended oligoarticular, 15 (21.4%)
poliarticular and 3 (4.3%) associated with psoriasis. The
average age at diagnosis was 3.5 SD 1.6 years (median
3 years). ANA positive were found in 41 (58.6%) patients.
The mean follow-up of patients was 4.44 SD 3.65 years.
There were 5 new cases of uveitis during treatment
(3 MTX, 2 MTX-ETN or ETN and 0 with ADM only) and
10 cases presented to debut or before starting DMARDs
or biologic therapy. The incidence was 0.15 and 0.11 cases
per 100 patient / year, respectively (p> 0.05, t Student
test). The accompanying table describes the distribution of
new cases according to the ILAR category and adminis-
tered treatment during the follow up period.
Conclusion
The incidence of occurrence of uveitis in our series of JIA
patients at high risk of uveitis is comparable to that
described in the literature (22.8%) and similar between
patients who received MTX as monotherapy and those
who received MTX and ETN or ETN. We reported no
new cases of uveitis in patients treated with ADM,
although in 85% of cases ADA was recomended in
patients diagnosed with uveitis, with studies that have
shown that it is more effective than treating this complica-
tion with ETN. The number of cases that occurred during
treatment with ETN in our series of cases is too small to
infer a causal relationship, the stratification by immunolo-
gical profile, sick time, age or baseline severity of the
symptoms could influence the development of this
complication. Prospective comparative studies of
biological and non-biological DMARDs are needed to
assess the increase or decrease in the risk of uveitis asso-
ciated with JIA.
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